FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Boyd Gaming Corporation (NYSE:BYD) announced that the conference call to review the Company's fourth-quarter and full-year 2011 results will take place on Tuesday, February 21, at 12:00 p.m. Eastern. The conference call number is (866) 524-3160. No passcode is required. Please call up to 15 minutes in advance to ensure you are connected prior to the start of the call.

Fifth Street Finance Corp.(NYSE:FSC) announced that it will voluntarily transfer its stock exchange listing from The New York Stock Exchange to The NASDAQ Stock Market effective November 28, 2011.

TearLab Corporation (Nasdaq:TEAR) announced that it has closed its previously announced private placement of approximately 3.85 million units at a price of $1.82 per unit. Each unit consisted of one share of common stock and a warrant to purchase one share of common stock at an exercise price of US$1.86 per share. The Company has received total gross proceeds of approximately US$7 million.

Cooper Industries plc (NYSE:CBE) announced it will report financial results for the second quarter of 2011 on Thursday, July 21, 2011, prior to the opening of trading on the New York Stock Exchange. Copies of the Company's press release will be available on the Company's website, www.cooperindustries.com.

National Health Partners Inc. (NHPR)

Arthritis is a joint disorder featuring inflammation. A joint is an area of the body where two different bones meet. A joint functions to move the body parts connected by its bones. Arthritis literally means inflammation of one or more joints.

Duke Realty Corporation (NYSE:DRE), will hold its quarterly conference call to discuss second quarter results on Thursday, July 28, 2011, at 3:00 p.m. Eastern Time. This call is being webcast by Thomson Reuters and can be accessed at Duke's web site at www.dukerealty.com.

Power3 Medical Products, Inc. (PWRM)
Power3 Medical is a leading edge biotechnology company engaged in the early detection, monitoring, and targeting of diseases through the analysis of proteins. This dynamic team utilizes proteomics in the discovery of protein biomarkers, drug pathways, and mechanisms of disease.

Pages